CARLSBAD, Calif., June 12 /PRNewswire/ -- GenVault Corporation today announces Paul J. Mirabella, Chairman and CEO of Naviscan PET Systems Inc., has joined its Board of Directors. Mr. Mirabella has more than 30 years of experience in diagnostic imaging with GE Healthcare where he held leadership roles in technology, marketing and global business management. Drawing on this substantial background in diagnostics and the healthcare market, he will help guide GenVault's entry into new biosample management markets as well as streamline operational efficiencies.
"Mr. Mirabella's deep business experience and understanding of the healthcare industry will be extremely valuable as we develop new technologies to expand our addressable markets. We are extremely honored to welcome Mr. Mirabella as a key member of the GenVault team," said David Wellis, CEO of GenVault.
"Biosamples are the conduit of information from the patient to clinicians and researchers. Advances in the handling of these samples will result in more efficient diagnosis, therapy development and ultimately a healthier population. I'm pleased to participate in building such a critical solution," said Mr. Mirabella.
Mr. Mirabella's previous experience includes leadership roles at GE Healthcare in ultrasound, computed tomography (CT), magnetic resonance, and sales and services. Mr. Mirabella holds four patents in CT and has participated in a variety of successful global product launches. Prior to joining Naviscan, he was President and CEO of Global Diagnostic Imaging, while retaining responsibility for the commercial leadership of sales, marketing and services in the Americas. Mr. Mirabella obtained degrees in aerospace engineering and applied mechanics from Polytechnic Institute of New York and a Masters in mechanical engineering from the University of Central Florida. He is a graduate of the GE Business Management Program accredited by the University of Wisconsin-Whitewater.
|SOURCE GenVault Corporation|
Copyright©2008 PR Newswire.
All rights reserved